A Phase Ⅱa Clinical Study of CL-197 Capsules

This early-stage clinical trial tests a new antiretroviral drug called CL-197 in adults who have been recently diagnosed with HIV-1 infection and have never taken any HIV medication before, to evaluate its safety and how the body processes it. **You may be eligible if...** - You are between 18 and 60 years old - You have a BMI between 18.5 and 29.9 (and weigh at least 50 kg if male, or 45 kg if female) - You have been diagnosed with HIV-1 infection prior to screening - You have never taken any anti-HIV drugs or HIV vaccines before - You agree not to take other anti-HIV drugs during the trial **You may NOT be eligible if...** - You have previously received any HIV treatment or related vaccines - Your BMI or weight falls outside the required range - You have other significant health conditions your doctor would assess Talk to your doctor to see if this trial is right for you.